Japan’s Nikkei index rose to close at its highest level in three decades on Tuesday, as drugmakers’ shares led activity thanks to a report stating that a drug manufactured by Chujai Pharmaceuticals is effective in treating Covid-19 patients.<\/p>\n\n\n\n
The Nikkei index rose 0.09% to 28,164.34 points, after recovering from early lows, while the broader Topix index rose 0.16% to 1,857.94 points.<\/p>\n\n\n\n
chugai Pharmaceutical Company jumped 5.91% on news of a drug’s effectiveness, which helped boost the pharmaceutical companies’ index, up 1.68%.<\/p>\n\n\n\n
Other companies, such as Takeda Pharmaceuticals, Shionogi & Co also gained between 1.95% and 3.38%.<\/p>\n\n\n\n
The news of the Covid-19 treatment comes at a time when Japan intends to expand its declaration of a state of emergency to three provinces in the west of the country, including Osaka, to contain the spread of Covid-19, according to local media.<\/p>\n\n\n\n
Among other stocks, SoftBank Group’s share gained 1.36% after a fund it managed to sell part of its stake in Uber Technologies for $ 2 billion.<\/p>\n\n\n\n
Semiconductor stocks rose due to the prospect of stronger demand for chips, with Tokyo Electron adding 0.29% and Shin-Etsu Chemical adding 3.29%.<\/p>\n\n\n\n
<\/p>\n\n\n\n
Toyota shares slipped 0.59% and Honda fell 1.55%.<\/p>\n\n\n\n
The lowest-performing stock on the Topix 30 index was Nippon Telegraph and Telephone, which fell 2.54%, followed by Seven and I Holdings, which lost 2.08%.<\/p>\n","protected":false},"excerpt":{"rendered":"
Japan’s Nikkei index rose to close at its highest level in three decades on Tuesday, as drugmakers’ shares led activity thanks to a report stating that a drug manufactured by Chujai Pharmaceuticals is effective in treating Covid-19 patients. The Nikkei index rose 0.09% to 28,164.34 points, after recovering from early lows, while the broader Topix …<\/p>\n","protected":false},"author":9,"featured_media":32812,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[39,36],"tags":[6939,6971],"class_list":["post-39748","post","type-post","status-publish","format-standard","has-post-thumbnail","","category-global-stock-markets","category-market-updates","tag-japan","tag-nikkei"],"_links":{"self":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/39748","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/comments?post=39748"}],"version-history":[{"count":1,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/39748\/revisions"}],"predecessor-version":[{"id":39749,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/posts\/39748\/revisions\/39749"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/media\/32812"}],"wp:attachment":[{"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/media?parent=39748"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/categories?post=39748"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/noortrends.ae\/en\/wp-json\/wp\/v2\/tags?post=39748"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}